FDA approves first ultrasound imaging system for detecting breast cancer in women with dense breast tissue

The U.S. Food and Drug Administration has approved the first ultrasound device to detect breast cancer in women with tense tissue, to be used in conjunction with standard mammography for women with no breast cancer symptoms.

According to the U.S. National Cancer Institute, 40% of women have dense breasts, which can make standard mammograms difficult to interpret. The somo-v Automated Breast Ultrasound System (ABUS) uses high-frequency sound waves and computer analysis and is able to "scan an entire breast and produce several images for physician review in about a minute."

To read more about this ultrasound imaging system, click here.